Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new ...

We often think about heart disease as something that suddenly happens, like a heart attack, requiring a trip to the emergency ...

Amgen and Eli Lilly & Co. are testing their own drugs to lower Lp(a), though they're further behind in development.

The company’s shares declined in after-hours trading after the drug failed to reduce the risk of cardiovascular events in a ...

Researchers at Imperial College London have developed an AI tool that can analyze an electrocardiogram, or ECG, in less than two seconds and flag signs of heart failure and heart valve disease that ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Heart disease has long ...

Cytokinetics scored the first-ever win for a Phase 3 study in non-obstructive hypertrophic cardiomyopathy on Friday.

But new research suggests that those early adult years matter more than we might think. They are setting the stage for heart ...

Heart disease and kidney disease are closely linked, and kidney damage can remain silent for years. These simple blood, urine ...

A shocking incident involved a 26-year-old man who suffered a heart attack without any apparent risk factors. Following his ...